Abstract:Bhoowit Lerttiendamrong, Nattanan Treeratanapun, Voranaddha Vacharathit, Kasaya Tantiphlachiva, Phuphat Vongwattanakit, Sopark Manasnayakorn, Mawin Vongsaisuwon Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Correspondence: Mawin Vongsaisuwon, Department of Surgery, Faculty of Medicine, Chulalongkorn University, 1873 King Chulalongkorn Memorial Hospital, Rama IV Road, Pathum Wan, Bangkok, 10330, Thailand, Tel +66 897158888, Email Purpose: Clinical application of the ACOSOG Z0011 trial results allows clinically node-negative breast cancer patients who meet criteria to avoid axillary dissection even when 1– 2 sentinel lymph nodes (SLNs) are positive for metastatic disease. Intraoperative frozen section (iFS) analyses of SLNs were thought to reduce re-operation rates despite variable reported sensitivity and possibility of a false negative result. This study evaluated the rate of re-operations prevented by SLN iFS in a tertiary care hospital in Bangkok, Thailand, over a 6-year time-frame. Patients and Methods: From April 2016 to April 2022, 1284 sentinel lymph node biopsy (SLNB) procedures were performed. Of these, 214 cases were breast-conserving surgery in accordance with the ACOSOG criteria with concomitant usage of iFS. Clinicopathological features of these cases were collected and analyzed. Re-operation rates prevented by the additional intervention were reported. Results: Only five additional operations were prevented with the usage of 214 iFS. The discordance rate between frozen and permanent sections in terms of presence of metastatic disease and number of total lymph nodes was around 15%. Tumor staging, node staging, Nottingham histologic grading and lymphovascular invasion are significant predictors of SLN metastasis. Conclusion: iFS results in a very low prevention rate for follow-up ALND in patients with preoperative clinically negative axillary nodes and is associated with a non-negligible discordance rate with permanent sections. Our study suggests iFS may be avoided in most cases of early-stage clinically and radiographically node-negative breast cancer patients. Doing so may reduce surgical costs and total operative time without a significant impact on the overall quality of treatment and standard of care. Keywords: breast cancer, sentinel lymph node biopsy, intraoperative frozen section analysis, ACOSOG Z0011 Breast cancer is one of the leading causes of death in both developed and developing countries. 1 Surgery is the main treatment method in early-stage invasive breast cancer. 2 Treatment goals in early-stage breast cancer are tumor eradication and prevention of recurrence. Surgical therapy includes breast-conserving surgery with or without axillary lymph node dissection (ALND) and/or postoperative radiation as indicated. 3 ALNDs have historically been a critical part in surgical breast cancer treatment. 4 However, ALNDs were more likely to result in lymphedema compared to sentinel lymph node biopsy (SLNB), with no significant differences between the overall survival of both procedures. 5 A historical switch from ALND to SLNB was implemented in the 1990s 4 . The ACOSOG Z0011 randomized controlled trial provided concrete evidence for the trend and demonstrated that the 10-year overall survival for breast cancer patients who had undergone SLNB was not inferior to those treated with ALND. Inclusion criteria for the Z0011 trial were breast cancer patients treated with breast-conserving therapy and adjuvant systemic therapy with clinical T1 or T2 node-negative disease (by palpation) and 1 or 2 sentinel lymph node (SLN) metastases. 6,7 The International Breast Cancer Study Group 23–01 (IBCSG 23–01) and After Mapping of the Axilla: Radiotherapy Or Surgery? (AMAROS) clinical trials had also been performed to address the necessity of ALND. 8,9 In response to the Z0011 trial, surgeons at MD Anderson, the United States of America, had significantly reduced ALND surgeries since 2012. 10 As of 2017, SLNB has replaced ALND as the standard of care for those with a clinically negative axilla or N0 disease to reduce morbidity. 11 It had also been proven that SLNB was more cost-effective than ALND. 12 Figure 1 Patient selection flowchart. Abbreviations : SLNB, sentinel lymph node biopsy; KCMH, King Chulalongkorn Memorial Hospital. SLNB is based on the concept that if the SLN is negative for cancer, the other lymph nodes in that group will also be negative. Intraoperative SLNB was used to spare a second procedure, while permanent histopathology sections were used as a confirmatory assessment. 13 However, frozen section (FS) detection -Abstract Truncated-

Axillary dissection versus non dissection in negative sentinel node biopsy patients

Role of Number of Sentinel Nodes in Predicting Non-Sentinel Node Metastasis in Breast Cancer

High Risk For Non-Sentinel Node Metastasis In Breast Cancer Patients With Sentinel Node Metastases

Axillary Dissection vs. no Axillary Dissection in Breast Cancer Patients With Positive Sentinel Lymph Node: A Single Institution Experience

Axillary Lymph Node Dissection Can Be Omitted in Breast Cancer Patients With Mastectomy and False-Negative Frozen Section in Sentinel Lymph Node Biopsy

Which patients with sentinel node-positive breast cancer can avoid axillary dissection?

Efficacy of sentinel lymph-node biopsy after neoadjuvant chemotherapy in clinically axilla node-negative patients

Axillary management in patients with clinical node-negative early breast cancer and positive sentinel lymph node: a systematic review and meta-analysis

Is Sentinel Lymph Node Biopsy a Viable Alternative to Axillary Lymph Node Dissection in Breast Carcinoma Patients Who Have Received Neo-Adjuvant Chemotherapy?

[Safety of Omitting Axillary Lymph Node Dissection in Primary Breast Cancer Patients with Negative Sentinel Lymph Nodes].

De-Escalation of Axillary Surgery in Clinically Node-Positive Breast Cancer Patients Treated with Neoadjuvant Therapy: Comparative Long-Term Outcomes of Sentinel Lymph Node Biopsy versus Axillary Lymph Node Dissection

Is Routine Intraoperative Frozen Section Analysis of Sentinel Lymph Nodes Necessary in Every Early-Stage Breast Cancer?

Can axillary lymphadenectomy be avoided in breast cancer with positive sentinel lymph node biopsy? Predictors of non-sentinel lymph node metastasis

Research progress of axillary management approach for 1-2 sentinel lymph node positive early stage breast cancer patients

The value of axillary ultrasonography in predicting non-sentinel lymph node metastasis in breast cancer patients

Is my patient an appropriate candidate for sentinel node biopsy? Less axillary surgery, for the right patients. Critical review and grades of recommendation

The Ongoing Necessity of Sentinel Lymph Node Biopsy for cT1-2N0 Breast Cancer Patients

Axillary Lymph Node Dissection for Breast Cancer: Efficacy and Complication in Developing Countries

Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer?

Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

Clinical research in endoscopically axillary sentinel lymph node biopsy for breast cancer